Optimizing the Composition of Bone Marrow for Allogeneic Transplantation

1 February 1995

journal article
review article
Published by Mary Ann Liebert Inc in Journal of Hematotherapy

Vol. 4 (1) , 53-60
https://doi.org/10.1089/scd.1.1995.4.53

Abstract

Graft versus host disease, graft failure, and disease relapse remain significant impediments to successful allogeneic transplantation. Ex vivo engineering of the graft offers the opportunity to modify the cellular composition to overcome these problems. This review describes recent developments that employ this approach.

Keywords

This publication has 34 references indexed in Scilit:

SELECTIVE DEPLETION OF CD8+ CELLS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER BONE MARROW TRANSPLANTATION A RANDOMIZED CONTROLLED TRIAL
Transplantation, 1994
Interferon-α And Donor Buffy Coat Transfusions For Treatment Of Relapsed Chronic Myeloid Leukemia After Allogeneic Bone Marrow Transplantation
Transplantation, 1993
Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia.
The Journal of Experimental Medicine, 1992
A DECREASE IN GRAFT-VS.-HOST DISEASE WITHOUT LOSS OF GRAFT-VS.-LEUKEMIA REACTIVITY AFTER MHC-MATCHED BONE MARROW TRANSPLANTATION BY SELECTIVE DEPLETION OF DONOR NK CELLS IN VIVO
Transplantation, 1992
Successful Allogeneic Transplantation of T-Cell–Depleted Bone Marrow from Closely HLA-Matched Unrelated Donors
New England Journal of Medicine, 1990
SPECIFIC RECOGNITION OF HUMAN LEUKEMIC CELLS BY ALLOGENEIC T CELL LINES
Transplantation, 1989
T CELL DEPLETION FOR GRAFT-VERSUS-HOST-DISEASE PROPHYLAXIS
Transplantation, 1989
EVIDENCE THAT LARGE GRANULAR LYMPHOCYTES OF DONOR ORIGIN MEDIATE ACUTE GRAFT-VERSUS-HOST DISEASE
Transplantation, 1989
T CELL SUBSETS AND GRAFT-VERSUS-HOST DISEASE
Transplantation, 1987
Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences.
The Journal of Experimental Medicine, 1986